605 related articles for article (PubMed ID: 32000075)
21. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
[TBL] [Abstract][Full Text] [Related]
22. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
Maciejewski JP; Selleri C
Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
[TBL] [Abstract][Full Text] [Related]
23. Serial morphologic observation of bone marrow in aplastic anemia in children.
Bessho F; Imashuku S; Hibi S; Tsuchida M; Nakahata T; Miyazaki S; Kojima S; Tsukimoto I; Hamajima N;
Int J Hematol; 2005 Jun; 81(5):400-4. PubMed ID: 16158820
[TBL] [Abstract][Full Text] [Related]
24. [Differences in the bone marrow histopathology between pediatric acquired aplastic anemia and refractory cytopenia of childhood].
Wang J; Wu XR; Qin X; Yin MZ; Shen P
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):699-703. PubMed ID: 32610381
[No Abstract] [Full Text] [Related]
25. Childhood myelodysplastic syndrome.
Chatterjee T; Choudhry VP
Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
[TBL] [Abstract][Full Text] [Related]
26. [A study of hypoplastic myelodysplastic syndrome].
Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
28. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
29. Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
Zuo Y; Cheng Y; Zhang L; Qin Y; Luo H
Hematology; 2019 Dec; 24(1):480-486. PubMed ID: 31210595
[No Abstract] [Full Text] [Related]
30. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.
Kasahara S; Hara T; Itoh H; Ando K; Tsurumi H; Sawada M; Yamada T; Ohnishi H; Moriwaki H
Br J Haematol; 2002 Jul; 118(1):181-8. PubMed ID: 12100146
[TBL] [Abstract][Full Text] [Related]
31. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
[TBL] [Abstract][Full Text] [Related]
32. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
33. Classification of childhood aplastic anemia and myelodysplastic syndrome.
Niemeyer CM; Baumann I
Hematology Am Soc Hematol Educ Program; 2011; 2011():84-9. PubMed ID: 22160017
[TBL] [Abstract][Full Text] [Related]
34. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
35. The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.
Cada M; Segbefia CI; Klaassen R; Fernandez CV; Yanofsky RA; Wu J; Pastore Y; Silva M; Lipton JH; Brossard J; Michon B; Abish S; Steele M; Sinha R; Belletrutti M; Breakey V; Jardine L; Goodyear L; Sung L; Shago M; Beyene J; Sharma P; Zlateska B; Dror Y
Haematologica; 2015 May; 100(5):633-42. PubMed ID: 25682607
[TBL] [Abstract][Full Text] [Related]
36. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
[TBL] [Abstract][Full Text] [Related]
39. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]